Cargando…
EZH2 alterations in follicular lymphoma: biological and clinical correlations
The histone methyltransferase EZH2 has an essential role in the development of follicular lymphoma (FL). Recurrent gain-of-function mutations in EZH2 have been described in 25% of FL patients and induce aberrant methylation of histone H3 lysine 27 (H3K27). We evaluated the role of EZH2 genomic gains...
Autores principales: | Huet, S, Xerri, L, Tesson, B, Mareschal, S, Taix, S, Mescam-Mancini, L, Sohier, E, Carrère, M, Lazarovici, J, Casasnovas, O, Tonon, L, Boyault, S, Hayette, S, Haioun, C, Fabiani, B, Viari, A, Jardin, F, Salles, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436075/ https://www.ncbi.nlm.nih.gov/pubmed/28430172 http://dx.doi.org/10.1038/bcj.2017.32 |
Ejemplares similares
-
A gene-expression profiling score for outcome prediction disease in patients with follicular lymphoma: a retrospective analysis on three international cohorts
por: Huet, Sarah, et al.
Publicado: (2018) -
Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles
por: Dubois, Sydney, et al.
Publicado: (2019) -
The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma
por: Sarkozy, Clémentine, et al.
Publicado: (2017) -
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
por: Stevens, Wendy B.C., et al.
Publicado: (2017) -
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
por: Martínez-Laperche, C., et al.
Publicado: (2022)